Market Research Report

Global Acute Migraine Treatment Market Report By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Triptans, Dihydroergotamine, Nonspecific Migraine Medications, Analgesics), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, E-Commerce) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11220233
January 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Acute Migraine Treatment Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Regarding volume, the market was calculated XX Kilo Tons in 2021 and forecast to touch XX Kilo Tons by 2028 with a CAGR of XX% during 2022-2028.

Migraine is a recurring neurological condition that causes moderate to intense headaches, often accompanied by symptoms related to the autonomic nervous system. Acute migraine treatment is the process of managing the symptoms of a migraine headache. The primary goal of acute migraine treatment is to stop the migraine headache as soon as possible and to alleviate the associated symptoms. There are several medications that can be used for this purpose, including over-the-counter (OTC) medications and prescription medications. 

Market Dynamics 

The increasing prevalence of migraines, a chronic neurological disorder, drives the market for acute migraine treatment. Moreover, the growing awareness of migraines as a legitimate health condition is also driving the market as more people seek treatment for them. The growing availability of effective treatments for migraines is expected to boost the acute migraine treatment market growth. The development of new and more effective migraine treatments is also driven by the increasing demand for more personalized treatment options. However, the high cost of treatment may impede the market growth. 

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of acute migraine treatment. The growth and trends of Acute Migraine Treatment Industry provide a holistic approach to this study. 

Market Segmentation

This section of the acute migraine treatment market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Type
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Triptans
  • Dihydroergotamine
  • Nonspecific Migraine Medications
  • Analgesics

By Distribution Channel
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-Commerce

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Acute Migraine Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Acute Migraine Treatment Market Share by Region (Representative Graph)

Global Acute Migraine Treatment Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the acute migraine treatment market include Teva Pharmaceutical, Hoffmann-La Roche Ltd., Johnson and Johnson, Amgen, AstraZeneca, Pfizer Inc., Merck & Co., Novartis AG, Eli Lilly and Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . ACUTE MIGRAINE TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Drug Type
           3.7.2 Market Attractiveness Analysis By Distribution Channel
           3.7.3 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL ACUTE MIGRAINE TREATMENT MARKET ANALYSIS BY DRUG TYPE
       6.1 Overview by Drug Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Drug Type
       6.4 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Historic and Forecast Sales by Regions
       6.5 Triptans Historic and Forecast Sales by Regions
       6.6 Dihydroergotamine Historic and Forecast Sales by Regions
       6.7 Nonspecific Migraine Medications Historic and Forecast Sales by Regions
       6.8 Analgesics Historic and Forecast Sales by Regions
 
7 . GLOBAL ACUTE MIGRAINE TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Historical and Forecast Data
       7.3 Analysis by Distribution Channel
       7.4 Hospitals Pharmacies Historic and Forecast Sales by Regions
       7.5 Retail Pharmacies Historic and Forecast Sales by Regions
       7.6 Drug Stores Historic and Forecast Sales by Regions
       7.7 E-Commerce Historic and Forecast Sales by Regions
 
8 . GLOBAL ACUTE MIGRAINE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America Sales Analysis
           8.3.1. Overview, Historic and Forecast Data  Sales Analysis
           8.3.2. North America By Segment Sales Analysis
           8.3.3. North America By Country Sales Analysis
           8.3.4. United State Sales Analysis
           8.3.5. Canada Sales Analysis
           8.3.6. Mexico Sales Analysis
       8.4. Europe Sales Analysis
           8.4.1. Overview, Historic and Forecast Data  Sales Analysis
           8.4.2. Europe by Segment Sales Analysis
           8.4.3. Europe by Country Sales Analysis
           8.4.4. United Kingdom Sales Analysis
           8.4.5. France Sales Analysis
           8.4.6. Germany Sales Analysis
           8.4.7. Italy Sales Analysis
           8.4.8. Russia Sales Analysis
           8.4.9. Rest Of Europe Sales Analysis
       8.5. Asia Pacific Sales Analysis
           8.5.1. Overview, Historic and Forecast Data  Sales Analysis
           8.5.2. Asia Pacific by Segment Sales Analysis
           8.5.3. Asia Pacific by Country Sales Analysis
           8.5.4. China Sales Analysis
           8.5.5. India Sales Analysis
           8.5.6. Japan Sales Analysis
           8.5.7. South Korea Sales Analysis
           8.5.8. Australia Sales Analysis
           8.5.9. Rest Of Asia Pacific Sales Analysis
       8.6. Latin America Sales Analysis
           8.6.1. Overview, Historic and Forecast Data  Sales Analysis
           8.6.2. Latin America by Segment Sales Analysis
           8.6.3. Latin America by Country Sales Analysis
           8.6.4. Brazil Sales Analysis
           8.6.5. Argentina Sales Analysis
           8.6.6. Peru Sales Analysis
           8.6.7. Chile Sales Analysis
           8.6.8. Rest of Latin America Sales Analysis
       8.7. Middle East & Africa Sales Analysis
           8.7.1. Overview, Historic and Forecast Data  Sales Analysis
           8.7.2. Middle East & Africa by Segment Sales Analysis
           8.7.3. Middle East & Africa by Country Sales Analysis
           8.7.4. Saudi Arabia Sales Analysis
           8.7.5. UAE Sales Analysis
           8.7.6. Israel Sales Analysis
           8.7.7. South Africa Sales Analysis
           8.7.8. Rest Of Middle East And Africa Sales Analysis
 
9 . COMPETITIVE LANDSCAPE OF THE ACUTE MIGRAINE TREATMENT COMPANIES
       9.1. Acute Migraine Treatment Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF ACUTE MIGRAINE TREATMENT INDUSTRY
       10.1. Top Companies Market Share Analysis
       10.2. Market Concentration Rate
       10.3. Teva Pharmaceutical
           10.3.1. Company Overview
           10.3.2. Company Revenue
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Hoffmann-La Roche Ltd.
           10.4.1. Company Overview
           10.4.2. Company Revenue
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Johnson and Johnson
           10.5.1. Company Overview
           10.5.2. Company Revenue
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Amgen
           10.6.1. Company Overview
           10.6.2. Company Revenue
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. AstraZeneca
           10.7.1. Company Overview
           10.7.2. Company Revenue
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Pfizer Inc.
           10.8.1. Company Overview
           10.8.2. Company Revenue
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Merck & Co.
           10.9.1. Company Overview
           10.9.2. Company Revenue
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Novartis AG
           10.10.1. Company Overview
           10.10.2. Company Revenue
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Eli Lilly and Company
           10.11.1. Company Overview
           10.11.2. Company Revenue
           10.11.3. Products
           10.11.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Drug Type (Kilo Tons and USD MN)
  •  Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Market Sales by Geography (Kilo Tons and USD MN)
  •  Triptans Market Sales by Geography (Kilo Tons and USD MN)
  •  Dihydroergotamine Market Sales by Geography (Kilo Tons and USD MN)
  •  Nonspecific Migraine Medications Market Sales by Geography (Kilo Tons and USD MN)
  •  Analgesics Market Sales by Geography (Kilo Tons and USD MN)
  •  Analysis Market by Distribution Channel (Kilo Tons and USD MN)
  •  Hospitals Pharmacies Market Sales by Geography (Kilo Tons and USD MN)
  •  Retail Pharmacies Market Sales by Geography (Kilo Tons and USD MN)
  •  Drug Stores Market Sales by Geography (Kilo Tons and USD MN)
  •  E-Commerce Market Sales by Geography (Kilo Tons and USD MN)
  •  Global Acute Migraine Treatment Market Sales by Geography (Kilo Tons and USD MN)
  •  North America Market Analysis (Kilo Tons and USD MN)
  •  United State Market Analysis (Kilo Tons and USD MN)
  •  Canada Market Analysis (Kilo Tons and USD MN)
  •  Mexico Market Analysis (Kilo Tons and USD MN)
  •  Europe Market Analysis (Kilo Tons and USD MN)
  •  Europe Market Estimate by Country (Kilo Tons and USD MN)
  •  United Kingdom Market Analysis (Kilo Tons and USD MN)
  •  France Market Analysis (Kilo Tons and USD MN)
  •  Germany Market Analysis (Kilo Tons and USD MN)
  •  Italy Market Analysis (Kilo Tons and USD MN)
  •  Russia Market Analysis (Kilo Tons and USD MN)
  •  Spain Market Analysis (Kilo Tons and USD MN)
  •  Rest of Europe Market Analysis (Kilo Tons and USD MN)
  •  Asia Pacific Market Analysis (Kilo Tons and USD MN)
  •  China Market Analysis (Kilo Tons and USD MN)
  •  Japan Market Analysis (Kilo Tons and USD MN)
  •  India Market Analysis (Kilo Tons and USD MN)
  •  South Korea Market Analysis (Kilo Tons and USD MN)
  •  Australia Market Analysis (Kilo Tons and USD MN)
  •  Rest of Asia Pacific Market Analysis (Kilo Tons and USD MN)
  •  Latin America Market Analysis (Kilo Tons and USD MN)
  •  Brazil Market Analysis (Kilo Tons and USD MN)
  •  Argentina Market Analysis (Kilo Tons and USD MN)
  •  Peru Market Analysis (Kilo Tons and USD MN)
  •  Chile Market Analysis (Kilo Tons and USD MN)
  •  Rest of Latin America Market Analysis (Kilo Tons and USD MN)
  •  Middle East & Africa Market Analysis (Kilo Tons and USD MN)
  •  Saudi Arabia Market Analysis (Kilo Tons and USD MN)
  •  UAE Market Analysis (Kilo Tons and USD MN)
  •  Israel Market Analysis (Kilo Tons and USD MN)
  •  South Africa Market Analysis (Kilo Tons and USD MN)
  •  Rest of Middle East and Africa Market Analysis (Kilo Tons and USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Acute Migraine Treatment Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Acute Migraine Treatment Market Size, by Region (Kilo Tons and USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Drug Type
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Drug Type (Kilo Tons and USD MN)
  •  Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Market Sales by Geography (Kilo Tons and USD MN)
  •  Triptans Market Sales by Geography (Kilo Tons and USD MN)
  •  Dihydroergotamine Market Sales by Geography (Kilo Tons and USD MN)
  •  Nonspecific Migraine Medications Market Sales by Geography (Kilo Tons and USD MN)
  •  Analgesics Market Sales by Geography (Kilo Tons and USD MN)
  •  Global Market Analysis by Distribution Channel (Kilo Tons and USD MN)
  •  Hospitals Pharmacies Market Sales by Geography (Kilo Tons and USD MN)
  •  Retail Pharmacies Market Sales by Geography (Kilo Tons and USD MN)
  •  Drug Stores Market Sales by Geography (Kilo Tons and USD MN)
  •  E-Commerce Market Sales by Geography (Kilo Tons and USD MN)
  •  Global Market Sales (Kilo Tons and USD MN)
  •  North America Market Sales (Kilo Tons and USD MN)
  •  Europe Market Sales (Kilo Tons and USD MN)
  •  Asia Pacific Market Sales (Kilo Tons and USD MN)
  •  Latin America Market Sales (Kilo Tons and USD MN)
  •  Middle East & Africa Market Sales (Kilo Tons and USD MN)
  •  Recent Development in Industry
  •  Top Companies Market Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials